List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 291 studies with search of: tyrosine
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Terminated L-Tyrosine Supplementation in Patients With Fibromyalgia
Condition: Fibromyalgia
Interventions: Drug: Tyrosine;   Drug: Placebo
2 Not yet recruiting Efficacy of Tyrosine in Restless Legs Syndrome
Condition: Restless Legs Syndrome (RLS)
Intervention: Dietary Supplement: L-Tyrosine
3 Completed
Has Results 		Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
Condition: Cancer
Intervention: Drug: Tyrosine kinase inhibitors
4 Completed Tyrosine for Methamphetamine Dependence - 1
Condition: Amphetamine-Related Disorders
Intervention: Behavioral: Tyrosine
5 Not yet recruiting Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Condition: Leukemia
Interventions: Drug: Azacitidine (AZA);   Drug: Tyrosine kinase inhibitor (TKI);   Drug: Azacitidine
6 Recruiting Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases
Conditions: Cancer;   Solid Tumor
Interventions: Biological: CPK dosage;   Other: Clinical exam
7 Active, not recruiting Malignant Pleural Effusion With ZD6474
Conditions: Lung Cancer;   Pleural Effusion
Intervention: Drug: ZD6474
8 Recruiting Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Conditions: Hypereosinophilic Syndrome;   Systemic Mastocytosis;   Chronic Myelomonocytic Leukemia;   Dermatofibrosarcoma
Intervention: Drug: imatinib mesylate
9 Completed B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients
Condition: Obesity
Intervention: Drug: tyrosine, green tea, caffeine
10 Terminated MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: multitargeted receptor tyrosine kinase inhibitor MP470;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: positron emission tomography
11 Recruiting Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Arsenic trioxide
12 Completed Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility
Conditions: Chronic Myeloid Leukemia;   Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib treatment
13 Completed Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies
Condition: Solid Tumors
Interventions: Drug: MP-470;   Drug: amuvatinib (MP-470)
14 Completed A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer
Condition: Renal Cell Carcinoma
Intervention: Drug: Perifosine
15 Unknown † First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Conditions: Lung Neoplasms;   Non-Small Cell Lung Cancer;   Adenocarcinoma, Bronchiolo-Alveolar
Intervention: Drug: Erlotinib
16 Terminated Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)
Condition: Chronic Myeloid Leukemia
Intervention: Drug: STI571 and PEG INTRON
17 Not yet recruiting Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: PCI-32765
18 Completed Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Drug: STI571
19 Recruiting Safety and Efficacy Study of Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Condition: Diffuse Large Cell B-lymphoma
Intervention: Drug: PCI-32765
20 Completed Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene
Conditions: Lung Cancer;   Non-small Cell Lung Cancer;   Bronchioloalveolar Cancer
Intervention: Drug: Gefitinib

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services